Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | MC4R | P32245 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NCF1 | P14598 | 2/20 | 0.32 |
| ▸ | CHKA | P35790 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 2/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL522905 | 0.89 | ALOX15 (0.32) | ALOX15 | |
| SCHEMBL21117053 | 0.81 | DRD2 (0.38) | ALOX15SIGMAR1 | |
| SCHEMBL18457919 | 0.81 | ALOX15 (0.35) | ALOX15 | |
| SCHEMBL9944691 | 0.81 | ALOX15 (0.59) | ALDH1A1PRMT6ALOX15SIGMAR1 | |
| SCHEMBL18426938 | 0.80 | MAPT (0.36) | KDM4EALDH1A1MAPTKDM1A | |
| SCHEMBL11637807 | 0.79 | HTT (0.36) | HTTLMNAKDM4EALDH1A1MAPT | |
| SCHEMBL26455581 | 0.79 | HTT (0.41) | HTTLMNAKDM4EALDH1A1MAPT | |
| SCHEMBL372272 | 0.79 | SIGMAR1 (0.33) | LMNAKDM4EALDH1A1TDP1PRMT6 | |
| SCHEMBL736240 | 0.79 | HTT (0.41) | HTTLMNAKDM4EALDH1A1MAPT | |
| SCHEMBL23277739 | 0.78 | GRIN2D (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110392707-A | The addition polymerization catalyst of microencapsulation | 建筑研究和技术有限公司 | 2019-10-29 | — | — | CN | claimed |
| CN-105705489-B | Compound as immunomodulator | 百时美施贵宝公司 | 2019-04-26 | — | — | CN | claimed |
| EP-3041822-A1 | COMPOUNDS USEFUL AS IMMUNOMODULATORS | Bristol-Myers Squibb Company (US) | 2016-07-13 | — | — | EP | claimed |
| WO-2015034820-A1 | COMPOUNDS USEFUL AS IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-03-12 | — | — | WO | claimed |
| EP-2454303-B1 | POLYURIC-BASED CLOTH ADHESIVE | MEDICAL ADHESIVE REVOLUTION GMBH (DE) | 2014-11-26 | — | — | EP | claimed |
| EP-2673310-B1 | TISSUE ADHESIVE BASED ON NITROGEN-MODIFIED ASPARTATES | MEDICAL ADHESIVE REVOLUTION GMBH (DE) | 2014-11-19 | — | — | EP | claimed |
| CN-103415543-A | Improved Stability of Polyurethane Polyol Blends Containing Halogenated Olefin Blowing Agents | ARKEMA INC | 2013-11-27 | — | — | CN | claimed |
| CN-103347925-A | Curable composition | DOW GLOBAL TECHNOLOGIES INC | 2013-10-09 | — | — | CN | claimed |
| US-8431565-B2 | Substituted imidazoheterocycles | CARA THERAPEUTICS, INC. (US) | 2013-04-30 | — | — | US | claimed |
| US-20090149450-A1 | SUBSTITUTED IMIDAZOHETEROCYCLES | CARA THERAPEUTICS, INC. (US) | 2009-06-11 | — | — | US | claimed |
| JP-62020517-A | — | — | None | — | — | JP | disclosed |
| CN-118652225-A | Phosphorus-free degradable CaSO (CaSOx resistance)4Small molecular scale inhibitor as well as preparation method and application thereof | 石家庄铁道大学 | 2024-09-17 | — | — | CN | disclosed |
| US-20240117229-A1 | ADHESIVE, LAMINATE, AND PACKAGING MATERIAL | DIC CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| US-11945900-B2 | Orthodontic articles prepared using a polycarbonate diol, polymerizable compositions, and methods of making the articles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-04-02 | — | — | US | disclosed |
| EP-4293091-A1 | ADHESIVE, LAMINATE, AND PACKAGING MATERIAL | DIC CORPORATION (JP) | 2023-12-20 | — | — | EP | disclosed |
| US-20070264180-A1 | METHOD OF DEACIDIZING A GAS BY PARTLY NEUTRALIZED MULTIAMINES | INSTITUT FRANCAIS DU PETROLE (FR) | 2007-11-15 | — | — | US | disclosed |
| CN-101031623-A | Low bake, low voc conductive primer | SHERWIN WILLIAMS CO (US) | 2007-09-05 | — | — | CN | disclosed |
| WO-2006124364-A1 | HYDROCARBON OR HYDROFLUOROCARBON BLOWN ASTM E4-84 CLASS I RIGID POLYURETHANE FOAMS | BAYER MATERIALSCIENCE LLC (US) | 2006-11-23 | — | — | WO | disclosed |
| US-20060258762-A1 | Hydrocarbon or hydrofluorocarbon blown ASTM E-84 class I rigid polyurethane foams | BAYER MATERIALSCIENCE LLC | 2006-11-16 | — | — | US | disclosed |
| JP-S6220517-A | CATALYST FOR EXCELLENTLY CURABLE POLYURETHANE | TOYO SODA MFG CO LTD | 1987-01-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149450-A1 | SUBSTITUTED IMIDAZOHETEROCYCLES | CNR1, CNR2, TRPV1 | HTT 3920/4885LMNA 3582/4885KDM4E 3477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.